Literature DB >> 22840414

What is the best treatment of drug-resistant trigeminal neuralgia in patients affected by multiple sclerosis? A literature analysis of surgical procedures.

Nicola Montano1, Fabio Papacci, Beatrice Cioni, Rina Di Bonaventura, Mario Meglio.   

Abstract

OBJECTIVE: Drug-resistant trigeminal neuralgia (TN) can complicate the clinical course of patients affected by multiple sclerosis (MS). Various surgical procedures have been reported for the treatment of this condition, but there is no agreement on the best management of these patients. To our knowledge, there is no critical literature analysis focusing on this particular topic. The aim of this study was to evaluate the clinical outcome of different surgical procedures utilized for drug-resistant TN in MS patients.
METHODS: We reviewed the literature about the studies reporting on surgical treatment of drug-resistant TN in MS patients. Case reports and case series less than 4 patients were excluded from the analysis. Nineteen studies were selected for the statistical analysis. To reduce the variability of the data, the selected studies were evaluated for the following outcome parameters: acute pain relief rate (APR), rate of recurrence (RR), pain free at follow-up rate (PF at FU) and complication rate (CR). For the statistical analysis, chi-square statistic, using the Fisher's exact test was utilized.
RESULTS: There was no procedure statistically superior in terms of APR rate in MS patients following the surgical treatment of TN. The highest RR was observed for percutaneous balloon compression (PBC) (60.2±14.4%). This result was statistically significant when compared to gamma knife surgery (GKS) (p=0.0129) and microvascular decompression (MVD) (p=0.0281). MVD together with percutaneous radiofrequency rhizothomy (PRR) was associated with a statistically better PF at FU rate (56.5±16.8% and 73.5±14.2%, respectively). However PBC and MVD showed statistical significant minor CR compared to other techniques (no complications and 18.7±17.4%, respectively).
CONCLUSION: Our study shows no differences in the short term results among different procedures for TN in MS patients. Each technique demonstrate advantages and limits in terms of long term pain, recurrence rate and complication rate. Each patient should be accurately informed on pros and cons of each procedure in order to be involved in the most appropriate choice.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22840414     DOI: 10.1016/j.clineuro.2012.07.011

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  9 in total

Review 1.  The role of radiosurgery in trigeminal neuralgia.

Authors:  Laura Fariselli; Francesco Ghielmetti; Davide Bosetti; Angelo Franzini; Marcello Marchetti
Journal:  Neurol Sci       Date:  2017-05       Impact factor: 3.307

2.  Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain.

Authors:  Martin Jakobs; Sigrid Schuh-Hofer; Andreas Unterberg; Rezvan Ahmadi
Journal:  J Vis Exp       Date:  2017-05-10       Impact factor: 1.355

Review 3.  Efficacy of Gamma Knife radiosurgery in the management of multiple sclerosis-related trigeminal neuralgia: a systematic review and meta-analysis.

Authors:  Alfio Spina; Gianluca Nocera; Nicola Boari; Sandro Iannaccone; Pietro Mortini
Journal:  Neurosurg Rev       Date:  2021-02-20       Impact factor: 3.042

4.  Efficacy and safety of radiofrequency in the treatment of trigeminal neuralgia: a systematic review and meta-analysis.

Authors:  Congyang Yan; Qianxi Zhang; Cheng Liu; Jiali Yang; Hu Bian; Jun Zhu; Tongqing Xue
Journal:  Acta Neurol Belg       Date:  2021-05-14       Impact factor: 2.471

Review 5.  Advances in diagnosis and treatment of trigeminal neuralgia.

Authors:  Nicola Montano; Giulio Conforti; Rina Di Bonaventura; Mario Meglio; Eduardo Fernandez; Fabio Papacci
Journal:  Ther Clin Risk Manag       Date:  2015-02-24       Impact factor: 2.423

6.  Efficacy and Safety of Repeated Percutaneous Radiofrequency Thermocoagulation for Recurrent Trigeminal Neuralgia.

Authors:  Guangzhao Liu; Yumin Du; Xiaowen Wang; YuE Ren
Journal:  Front Neurol       Date:  2019-01-18       Impact factor: 4.003

Review 7.  Symptomatic management in multiple sclerosis.

Authors:  Pushkar Shah
Journal:  Ann Indian Acad Neurol       Date:  2015-09       Impact factor: 1.383

8.  The Successful Treatment of Severe Trigeminal Neuralgia by a Single Mandibular Nerve Block and Subsequent Natalizumab Administration in a Patient with Multiple Sclerosis.

Authors:  Ryohei Norioka; Yoko Warabi; Hiroaki Matayoshi; Eiji Isozaki
Journal:  Cureus       Date:  2020-04-12

Review 9.  Metabolomics as a promising tool for improving understanding of multiple sclerosis: A review of recent advances.

Authors:  Zhicheng Liu; Jeffrey Waters; Bin Rui
Journal:  Biomed J       Date:  2022-01-15       Impact factor: 7.892

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.